Comments
Commented by Fabian Lorenz on June 23rd, 2025 | 07:10 CEST
DRONE STOCK: Volatus Aerospace benefits from NATO billions - and much more! BUY RECOMMENDATION!
The drone revolution has only just begun. In Ukraine, remote-controlled aircraft have become a game changer in modern warfare. Defense is just one of many industries being disrupted by drones equipped with the latest camera technology and AI. These all-rounders can transport goods to remote areas, inspect buildings and bridges for structural damage, and even act as aerial fire extinguishers during high-rise fires. One insider tip in this billion-dollar market is Volatus Aerospace. The Canadian company offers numerous services - from drone pilot training to surveillance - and generates recurring revenue streams. The latest capital increase was oversubscribed and should give the stock fresh momentum. Analysts forecast that revenues will soon exceed CAD 80 million and are issuing a "Buy" recommendation for the stock.
Read
Commented by André Will-Laudien on June 23rd, 2025 | 07:05 CEST
High-tech boom 3.0! Is another 100% possible with Palantir, SAP, MiMedia, and TeamViewer?
Artificial intelligence and big data remain the big topics on the stock markets alongside defense. This is leading to daily gains for high-tech and defense stocks. Investors increasingly appear to view the capital markets as a one-way street, with valuations seemingly taking a back seat. Interestingly, Europe is ahead of the US. Since the tariff dip in April alone, the EURO STOXX 50 has gained around 20%. With Israel's attack on Iran, some uncertainty is now entering the market. However, many investors do not believe the big bull market will change. Only the Shiller P/E ratio for the S&P 500, at over 36, is a cause for caution, given that the long-term average is around 17. But does anyone care? The party is in full swing, and critics are not welcome. So, where do the opportunities lie in the weeks ahead?
Read
Commented by Nico Popp on June 23rd, 2025 | 07:00 CEST
This trillion-dollar disruption is also sustainable for your portfolio: Argo Living Soils, Beyond Meat, Heidelberg Materials
Investors have seen it before: ambitious plans and grand revolutions that ultimately come to nothing - at least from an investor's perspective. The best example is the vegan revolution led by Beyond Meat – the Company's share chart certainly leaves a bad taste for any investor. But does that mean investors should be particularly critical of major innovations? We explain which disruptions truly deliver sustainable returns. It is all about sustainable construction - and benefits for all parties involved.
Read
Commented by Armin Schulz on June 20th, 2025 | 07:00 CEST
Critical metals, crisis-proof profits: BYD, Power Metallic Mines, and Nordex are your key
The global race for clean mobility and energy is fueling an unprecedented hunger for raw materials. Copper, nickel, lithium, and rare earths are the hidden building blocks of the climate transition and are becoming new, strategically vital cornerstones of the economy. Those who secure these critical metals and use them innovatively will dominate the future. But supply risks and price shocks loom. So how can this race be won? It will take companies that revolutionize the entire value chain, from mining to green technology. This is where the strategies of BYD, Power Metallic Mines, and Nordex come into play.
Read
Commented by Fabian Lorenz on June 20th, 2025 | 06:55 CEST
Declaration of war on the pharmaceutical industry? Bayer, Novo Nordisk, and insider tip PanGenomic Health
Has US Health Secretary Robert F. Kennedy Jr. declared war on the traditional pharmaceutical industry? That is certainly what former Trump press secretary and current podcaster Anthony Scaramucci seems to think. The reason for this is the complete overhaul of the US Vaccine Advisory Committee. One company set to benefit from the new US Health Secretary is PanGenomic Health. The Company plans to launch a new digital health and alternative medicine business this year. If it manages to secure even a small share of this billion-dollar market, its share price could multiply. The price target for Novo Nordisk was recently reduced. The stock is working on bottoming out, and there was a success for the blockbuster in the US. Bayer's stock is trending favorably. Regular positive news is currently overshadowing the legal disputes in the US. There was recently some positive news to report there.
Read
Commented by Armin Schulz on June 19th, 2025 | 07:10 CEST
Profit from Palantir? You can get in on the action with Argo Living Soils and D-Wave Quantum!
While AI and quantum computing have already experienced their first boom phases, an underestimated revolution is looming! High-performance materials are transforming our physical world. Graphene-optimized building materials not only increase the compressive strength of infrastructure by up to 30% and halve CO₂ emissions but also pave the way for "smart" roads and buildings. Those who recognized the opportunities offered by artificial intelligence early on were able to secure a rare opportunity. Quantum computing is still in its infancy but has already seen its first hype wave. The innovation of graphene materials is creating a new and unique opportunity for early investors. We take a look at Palantir, Argo Living Soils, and D-Wave Quantum as representative examples from each sector.
Read
Commented by Fabian Lorenz on June 19th, 2025 | 07:05 CEST
Share price speculation thanks to drones and artificial intelligence: Rheinmetall, BioNTech, and NetraMark shares
Drones and artificial intelligence are set to revolutionize entire industries. Listed companies that play a leading role in this transformation hold significant upside potential, such as NetraMark. Using artificial intelligence, the Company helps pharmaceutical and biotech companies shorten development times and reduce costs. NetraMark also aims to help shape industry trends. BioNTech, too, relies on AI for its research, frequently acquiring specialized companies. Perhaps NetraMark will be next? In any case, the Canadians would still be a bargain. Rheinmetall shares, on the other hand, are certainly not cheap. However, the multibillion-euro defense budgets for rearmament in Europe are fueling speculation. In order to be able to deliver not only tanks, howitzers, and ammunition quickly, but also cutting-edge technology, Germany's largest defense contractor is focusing on partnerships. This is evident in its latest partnership, which is expected to enable Rheinmetall to deliver combat and kamikaze drones quickly.
Read
Commented by André Will-Laudien on June 19th, 2025 | 07:00 CEST
Biotech: Weight loss and cancer – Takeovers ahead! Keep an eye on Evotec, Vidac Pharma, Eli Lilly, and Novo Nordisk!
For nearly two years, the biotech sector remained largely stagnant. But in the last few weeks, some heavily bombed-out life science stocks have seen significant gains, and takeovers are back on the agenda. Eli Lilly is acquiring Verve Therapeutics, and BioNTech has finally reached an agreement with CureVac. The carousel is slowly starting to turn, and tensions are rising. New rumors are circulating, especially as major pharma stocks like Eli Lilly and Novo Nordisk are showing negative 12-month performance - despite record highs in the major indices.
What is next?
Commented by Armin Schulz on June 18th, 2025 | 07:05 CEST
Plug Power's comeback, Desert Gold's crisis protection, BP's oil boom: Your triple 200% opportunity for 2025
Savvy investors see opportunities in turbulent markets: three sectors now offer explosive return potential. Hydrogen stocks are poised for a spectacular turnaround after their slump, gold is shining as a shield against crises with record prices confirming the trend, while oil is benefiting from geopolitical upheaval in the Middle East. Those who take advantage of this momentum could realize substantial gains. The key is to look for companies that have the potential to double in value. Plug Power, Desert Gold, and BP are particularly promising.
Read
Commented by Fabian Lorenz on June 18th, 2025 | 07:00 CEST
Almonty Industries: Analysts raise target price! 75% Upside Potential! CEO clearly backs Rheinmetall and Co. on CNBC
Anything other than further price increases for Almonty shares in the coming weeks would be a surprise. The tungsten gem is facing a hot summer. The main driver for the share price will be the commissioning of the mega mine in South Korea. Due to the increasing visibility of revenue and profit growth, analysts have significantly raised their price targets for the share. With its unique market position, the Company remains attractively valued compared to its peers. With the planned upcoming NASDAQ listing, the stock is expected to attract greater attention from US investors. That Almonty is gaining more visibility is underscored by CEO Lewis Black's recent interview with CNBC. In it, Black emphasized that Almonty already supplies 85% of its production to the defense sector. Rheinmetall, for example, needs tungsten to harden ammunition.
Read